Table 2.
Tumor characteristics and oncological outcomes
| High-risk patients (N = 31) |
Low- and intermediate-risk patients (N = 43) |
Overall cohort (N = 74) |
||
|---|---|---|---|---|
| Tumor diameter (cm), median (IQR) | 2 (1.5–2.5) | 2 (1–2.5) | 2 (1–2.5) | |
| Median number of tumors (range) | 1 (1–4) | 1 (1–4) | 1 (1–4) | |
| T stage at first TURBT, N (%) | Ta | 4 (13) | 43 (100) | 47 (64) |
| ROL1 T1 | 16 (52) | – | 16 (22) | |
| ROL2 T1 | 11 (35) | – | 11 (15) | |
| Recurrence, N (%) | No recurrence | 20 (65) | 35 (81) | 55 (74) |
| Rec. within 3 months | 1 (3) | 3 (7) | 4 (5) | |
| Rec. after 3 months | 8 (26) | 5 (12) | 13 (18) | |
| Pathology report at first recurrence, N (%) | LGTa | 2 (22) | 8 (100) | 10 (53) |
| HGTa | 2 (22) | 0 (0) | 2 (11) | |
| HGT1 | 7 (78) | 0 (0) | 7 (37) | |
| Progression to MIBC, N (%) | No | 31 (100) | 43 (100) | 74 (100) |
| Yes | 0 (0) | 0 (0) | 0 (0) | |
HG = high grade; IQR = interquartile range; LG = low grade; MIBC = muscle-invasive bladder cancer; ROL = Rete Oncologica Lombarda; TURBT = transurethral resection of bladder tumor.